Business Context and Reporting Period
Company: Duos Technologies Group, Inc. (DUOT)
Filing Type: Form 8-K (Current Report)
Date of Report: May 27, 2025
Reporting Period: Event date May 27, 2025; Prospectus supplement filed May 28, 2025.
The Company entered into a Second Amendment to its At-The-Market (ATM) Issuance Sales Agreement with Ascendiant Capital Markets, LLC, expanding its ability to raise capital through the sale of common stock.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a disclosure of a material definitive agreement regarding equity issuance.
- Previous ATM Offering Limit: $7,500,000 (aggregate offering price under the Original Agreement).
- Additional Offering Capacity: $10,500,000 (increase authorized under the Second Amendment).
- Total Potential Offering Capacity: $18,000,000 (cumulative under the amended Sales Agreement).
- Security Type: Common Stock, par value $0.001 per share.
Material Changes
The primary material change is the expansion of the Company's equity financing facility:
- Agreement Amendment: The Second Amendment, dated May 27, 2025, increased the amount of Placement Shares that may be sold under the Sales Agreement by $10,500,000.
- Regulatory Filing: A prospectus supplement was filed with the SEC on May 28, 2025, relating to the offer and sale of the additional shares.
- Registration Basis: The offering is made pursuant to an effective "shelf" registration statement on Form S-3 (No. 333-272603), originally filed in June 2023.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing does not provide specific financial guidance or operational outlook. It confirms the Company's intent to sell shares "from time to time" based on market conditions and Company instructions.
Terms of Sale:
- Sales will be conducted as an "at the market offering" under Rule 415 of the Securities Act.
- The Company retains the right to set sales parameters, including share volume, timing, daily limits, and minimum price floors.
- Either the Company or the Agent may suspend or terminate the agreement upon written notice.
Risks and Contingencies:
- Dilution: The issuance of additional shares will result in dilution to existing shareholders.
- Market Conditions: The actual amount raised depends on market conditions and the Company's discretion to initiate sales.
- Legal Compliance: Sales are subject to applicable state and federal securities laws and Nasdaq rules.
Investor Verification Checklist
- Verify the current share price and trading volume of DUOT on the Nasdaq Stock Market to assess potential dilution impact.
- Review the full text of the Second Amendment (Exhibit 1.3) and the Original Agreement (Exhibit 1.1) for specific termination clauses and fee structures.
- Check the Company's most recent 10-Q or 10-K filings for current cash balances and liquidity needs to understand the urgency of this capital raise.
- Confirm the status of the prospectus supplement filed on May 28, 2025, via the SEC EDGAR database.